| RS1557374482 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1557374667 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Abnormality of the musculature |
| RS1557380496 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1557380616 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Duchenne muscular dystrophy |
| RS1557380670 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS1557380685 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1557383751 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS1557383761 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS1557396600 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1557396632 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS1557412510 |
MTM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe X-linked myotubular myopathy, Inborn genetic diseases |
| RS1557412659 |
MTM1
|
Health Risk |
Pathogenic |
— |
| RS1557413092 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS1557413783 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS1557414505 |
MTM1
|
Health Risk |
Pathogenic |
— |
| RS1557414513 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS1557414792 |
MTM1
|
Health Risk |
Likely pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS1557414802 |
MTM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS1557415137 |
MTM1
|
Health Risk |
Likely pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS1557437034 |
PGM1
|
Health Risk |
Pathogenic |
PGM1-congenital disorder of glycosylation, PGM1-congenital disorder of glycosylation |
| RS1557438039 |
PEX14
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder, complementation group K |
| RS1557438186 |
HPDL
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1557444106 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1557445467 |
PGM1
|
Health Risk |
Likely pathogenic |
— |
| RS1557446524 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1557447255 |
DHDDS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 59, Developmental delay and seizures with or without movement abnormalities |
| RS1557451154 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS1557451662 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1557452216 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1557457623 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1557458134 |
ATAD3A
|
Health Risk |
Pathogenic |
Harel-Yoon syndrome, Pontocerebellar hypoplasia |
| RS1557458426 |
CLCNKA
|
Health Risk |
Pathogenic/Likely pathogenic |
Deafness, Hearing loss |
| RS1557458562 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1557458593 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1557459395 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1557460984 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1557461219 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1557461427 |
RERE
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without anomalies of the brain, eye |
| RS1557461836 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1557464361 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1557465450 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1557466604 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1557466834 |
ACADM
|
Health Risk |
Conflicting classifications of pathogenicity |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1557467049 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1557468189 |
CLCNKB
|
Health Risk |
Pathogenic |
Bartter disease type 3, Bartter disease type 3 |
| RS1557468846 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1557470829 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1557472348 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1557472384 |
MUTYH
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS1557474374 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1557474906 |
MUTYH
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS1557478316 |
VPS13D
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome, Inborn genetic diseases |
| RS1557479812 |
GALE
|
Health Risk |
Pathogenic/Likely pathogenic |
UDPglucose-4-epimerase deficiency, Thrombocytopenia 13 |
| RS1557481282 |
MUTYH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1557482167 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1557484399 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1557485170 |
BSND
|
Health Risk |
Pathogenic |
— |
| RS1557485553 |
MUTYH
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1557486313 |
MUTYH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1557487125 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1557487179 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1557487475 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1557487793 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1557488140 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS1557491929 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1557492431 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1557492581 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1557497881 |
GLMN
|
Health Risk |
Pathogenic |
Blue rubber bleb nevus, Blue rubber bleb nevus |
| RS1557500194 |
PLOD1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS1557500853 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS1557506070 |
FUCA1
|
Health Risk |
Pathogenic |
Fucosidosis, Fucosidosis |
| RS1557507208 |
MYSM1
|
Health Risk |
Pathogenic |
Bone marrow failure syndrome 4, Bone marrow failure syndrome 4 |
| RS1557508272 |
CTRC
|
Health Risk |
Likely pathogenic |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS1557508308 |
PADI3
|
Health Risk |
Pathogenic |
Central centrifugal cicatricial alopecia, Central centrifugal cicatricial alopecia |
| RS1557510081 |
FUCA1
|
Health Risk |
Pathogenic |
Fucosidosis, Fucosidosis |
| RS1557515779 |
MFN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2A2, Charcot-Marie-Tooth disease type 2 |
| RS1557518298 |
MYSM1
|
Health Risk |
Pathogenic |
Bone marrow failure syndrome 4, Bone marrow failure syndrome 4 |
| RS1557519001 |
MFN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 2 |
| RS1557521949 |
MFN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 2 |
| RS1557522794 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Hereditary motor neuron disease |
| RS1557522849 |
MFN2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2A2 |
| RS1557523211 |
USP24
|
Health Risk |
Likely pathogenic |
Short stature, Short stature |
| RS1557524703 |
MFN2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease |
| RS1557524814 |
MFN2
|
Health Risk |
Likely pathogenic |
— |
| RS1557525000 |
MFN2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1557525005 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease |
| RS1557525153 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease |
| RS1557531984 |
TOE1
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 7, Pontocerebellar hypoplasia type 7 |
| RS1557537223 |
MFN2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease |
| RS1557537346 |
MFN2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease |
| RS1557539004 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1557539119 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease |
| RS1557539450 |
PUM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Spinocerebellar ataxia 47, Inborn genetic diseases |
| RS1557541619 |
PUM1
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia 47, PUM1-associated developmental disability-ataxia-seizure syndrome |
| RS1557551678 |
CLDN19
|
Health Risk |
Pathogenic |
Renal hypomagnesemia 5 with ocular involvement, Renal hypomagnesemia 5 with ocular involvement |
| RS1557561340 |
PINK1
|
Health Risk |
Pathogenic |
Autosomal recessive early-onset Parkinson disease 6, Autosomal recessive early-onset Parkinson disease 6 |
| RS1557562343 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS1557563410 |
ST3GAL3
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 15 |
| RS1557567563 |
ORC1
|
Health Risk |
Pathogenic |
— |
| RS1557569037 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |